Immunohistochemistry of the tumor component for PD-L1 revealed positive PD-L1 expression (tumor proportion score = 30%, combined positive score = 31, Figure 4D) using the 22C3 antibody (Dako, Santa Clara, CA). The gene discussed is CD274; the disease is neoplasm.